Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › RNAi agents and compositions for inhibiting expression of apolipoprotein C-III (APOC3)

RNAi agents and compositions for inhibiting expression of apolipoprotein C-III (APOC3)

US Patent 11214801 · Granted Jan 4, 2022

Estimated economic value: $42,476,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Determining frequency offset of signal under test2025
RNAi agents for inhibiting expression of inhibin subunit beta E (INHBE), pharmac2025
RNAi agents for inhibiting expression of inhibin subunit beta E (INHBE), pharmac2025
5′-cyclo-phosphonate modified nucleotides2025
RNAi agents for inhibiting expression of activin receptor-like kinase 7 (ALK7), 2025
RNAi agents for inhibiting expression of complement factor B (CFB), pharmaceutic2025
RNAi agents and compositions for inhibiting expression of apolipoprotein C-III (2025
RNAi agents and compositions for inhibiting expression of apolipoprotein C-III (2025
RNAi agents and compositions for inhibiting expression of apolipoprotein C-III (2025
RNAi agents and compositions for inhibiting expression of apolipoprotein C-III (2025
RNAi agents and compositions for inhibiting expression of apolipoprotein C-III (2025
RNAi agents for inhibiting expression of HIF-2 alpha (EPAS1), compositions there2025